423 related articles for article (PubMed ID: 10403098)
1. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
2. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
Tabe Y; Nakamura A; Igari J
J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
[TBL] [Abstract][Full Text] [Related]
3. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
Jones RN; Barry AL; Gardiner RV; Packer RR
Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
[TBL] [Abstract][Full Text] [Related]
5. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
8. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
[TBL] [Abstract][Full Text] [Related]
9. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
Bannerman TL; Wadiak DL; Kloos WE
Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
[TBL] [Abstract][Full Text] [Related]
11. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia.
Nunes AP; Schuenck RP; Bastos CC; Magnanini MM; Long JB; Iorio NL; Santos KR
Braz J Infect Dis; 2007 Jun; 11(3):345-50. PubMed ID: 17684637
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Chaudhury A; Kumar AG
Indian J Med Microbiol; 2007 Jan; 25(1):50-2. PubMed ID: 17377353
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of four species of coagulase-negative staphylococci.
Fass RJ; Helsel VL; Barnishan J; Ayers LW
Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
[TBL] [Abstract][Full Text] [Related]
16. Emergence of teicoplanin-resistant coagulase-negative staphylococci.
Cercenado E; García-Leoni ME; Díaz MD; Sánchez-Carrillo C; Catalán P; De Quirós JC; Bouza E
J Clin Microbiol; 1996 Jul; 34(7):1765-8. PubMed ID: 8784585
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
Jansen B; Schumacher-Perdreau F; Pulverer G
Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
[TBL] [Abstract][Full Text] [Related]
18. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
19. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Low DE; McGeer A; Poon R
Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]